Therapeutics for Rare and Neglected Diseases program

E93886

The Therapeutics for Rare and Neglected Diseases program is a U.S. government initiative that accelerates the discovery and development of new treatments for rare and underserved diseases that lack adequate commercial investment.

AI illustration

How this image was made

AI-generated illustration of Therapeutics for Rare and Neglected Diseases program

This AI-generated illustration was produced by black-forest-labs/FLUX.2-dev (1024x1024) from a prompt written by openai/gpt-oss-120b from the entity's label + description.

Prompt

Generate an image of the Therapeutics for Rare and Neglected Diseases program (The Therapeutics for Rare and Neglected Diseases program is a U.S. government initiative that accelerates the discovery and development of new treatments for rare and underserved diseases that lack adequate commercial investment.)

All labels observed (2)

How this entity was disambiguated

Statements (34)

Predicate Object
instanceOf United States government program ⓘ
drug development program ⓘ
aim accelerate development of new therapeutics ⓘ
accelerate discovery of new therapeutics ⓘ
address diseases lacking adequate commercial investment ⓘ
de-risk therapeutic candidates for rare and neglected diseases ⓘ
collaboratesWith academic researchers ⓘ
non-profit organizations ⓘ
small biotechnology companies ⓘ
country United States ⓘ
field drug discovery ⓘ
neglected diseases ⓘ
rare diseases ⓘ
translational research ⓘ
focusesOn neglected tropical diseases ⓘ
rare diseases ⓘ
underserved diseases ⓘ
fundingSource United States federal government ⓘ
goal enable new treatments to reach patients with neglected diseases ⓘ
enable new treatments to reach patients with rare diseases ⓘ
hasAbbreviation TRND ⓘ
locatedIn Bethesda, Maryland ⓘ
operatedBy National Center for Advancing Translational Sciences ⓘ
National Institutes of Health ⓘ
parentOrganization National Institutes of Health ⓘ
partOf National Center for Advancing Translational Sciences ⓘ
previouslyPartOf National Human Genome Research Institute ⓘ
regulatoryFocus facilitating Investigational New Drug applications ⓘ
supportsStage early clinical development ⓘ
preclinical development ⓘ
typeOfSupport in-kind drug development expertise ⓘ
laboratory resources ⓘ
project management for therapeutic development ⓘ
usesModel public–private partnership ⓘ

How these facts were elicited

Referenced by (3)

Full triples — surface form annotated when it differs from this entity's canonical label.

National Center for Advancing Translational Sciences → operates → Therapeutics for Rare and Neglected Diseases program ⓘ
TRND → fullName → Therapeutics for Rare and Neglected Diseases ⓘ
linked to: Therapeutics for Rare and Neglected Diseases program
TRND → abbreviationFor → Therapeutics for Rare and Neglected Diseases ⓘ
linked to: Therapeutics for Rare and Neglected Diseases program